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Erratum
In the paper by Keefe & Mackie (Br. J. Cancer 1991, 64,
598-602), 'The relationship between risk of death from
clinical stage I cutaneous melanoma and thickness of primary
tumour: no evidence for steps in risk' some errors were
introduced in Table III, which is reproduced correctly below.
Table III Cases up to 2 mm thick
5-year surv. Unadjusted HR Adjusted HRa
n % 95% CI expo(p) 95% CI expo(p) 95% CI






























































































<0.70 205 96 91-98
0.71 -0.80 36 90 71-97 3.95 1.25- 12.44 4.62 1.43-14.91
0.81 -0.90 28 89 69-96 3.70 0.96-14.34 3.62 0.93-14.08
0.91-1.00 37 85 61-95 3.69 1.08- 12.62 3.95 1.14-13.65
1.01 -1.10 19 88 61 -97 3.55 0.74- 17.12 3.60 0.74-17.48
1.11-1.20 25 92 71-98 2.16 0.45-10.41 2.30 0.47-11.17
1.21 -1.30 22 91 68-98 2.67 0.55-12.83 2.31 0.48-11.19
1.31 -1.40 17 88 61-97 6.63 1.94-22.66 8.13 2.31 -28.64
1.41 -1.50 19 95 68-99 1.81 0.22-14.70 1.42 0.17-11.62
1.51-1.60 17 75 46-90 9.04 2.64-30.93 9.18 2.58-32.61
1.61-1.70 18 89 62-97 5.46 1.41-21.13 5.99 1.53-23.47
1.71 -1.80 29 86 66-94 4.40 1.29-15.03 3.99 1.16-13.79
1.81 -1.90 12 92 54-99 2.73 0.34-22.20 1.95 0.24-16.15
1.91-2.00 36 76 57-87 9.05 3.44-23.81 8.09 3.05-21.45
Continuous variable 520 - - 2.80 1.72-4.56 2.52 1.55-4.09
Survival from clinical Stage 1 primary cutaneous malignant melanoma first registered in Scotland
between 1979and 1983 inclusive. Cases0-2 mmthick, n = 520. HR = hazardratio. 'All resultsadjusted
forothervariablesinmodel. Onlystatistically significantresultsareshown. Hazardratiosforageandsite
derived from analysis using thickness factored in eight levels. Hazards ratios for thickness as a
continuous variable were dervied from a separate analysis.
The heading forTable IV should also read 'Cases up to 2 mm thick' and
the reference to Day et al. should read, Day, C.L., Sober, A.J., Kopf,
A.W. & 16 others.
Br. J. Cancer (1992), 65, 630 '." Macmillan Press Ltd., 1992